Key result
hSKCa3 channel gene CAG polymorphism shows no link to schizophrenia risk or disease severity.
Why the study?
Is the hSKCa3 channel gene CAG polymorphism associated with schizophrenia, its severity, or age at onset?
Case-Control
Is the hSKCa3 channel gene CAG polymorphism associated with schizophrenia, its severity, or age at onset?
The study found no evidence supporting the involvement of the hSKCa3 gene CAG polymorphism in schizophrenia.
Does not support hSKCa3 CAG polymorphism in schizophrenia; challenges prior associations while leaving other genetic contributions open.
Genetic anticipation, a phenomenon characterized by increased severity of symptoms and earlier age at onset of a disease in successive generations, is believed to be present in schizophrenia. In several neurodegenerative diseases showing anticipation, the mutation causing the disease is an expanded trinucleotide repeat. Therefore, genes containing trinucleotide repeats prone to expansion have become a suitable family of candidate genes in schizophrenia. A human calcium-activated potassium channel gene (hSKCa3), possibly mapping to chromosome 22q11-13, a region previously linked to schizophrenia, was recently described. This gene contains two contiguous expressed CAG repeat stretches. Recently, long allelic variants of one of these CAG repeats were found to be overrepresented in schizophrenic patients compared to normal controls. In this study we attempted to replicate this result and to study the relationship between the length of this CAG repeat on the one hand and the severity and age at onset of the disease on the other hand. No association with the disease or correlation with the severity of schizophrenia was identified. In addition, hSKCa3 was mapped to chromosome 1. Our results do not support the involvement of this particular CAG repeat-containing gene in schizophrenia.
No takes yet. Share an insight, caveat, or question.
Joober et al. (1999) conducted a case-control in Schizophrenia. hSKCa3 channel gene CAG polymorphism vs. Normal controls was evaluated on Association with schizophrenia and correlation with disease severity and age at onset. The hSKCa3 channel gene CAG polymorphism showed no association with schizophrenia or correlation with disease severity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: